Table 1.
Baseline demographics and patient characteristics
| CONV | UTR | UCR | p+ | |
|---|---|---|---|---|
| N participants | 16 | 18 | 16 | |
| Male [%] | 63 | 61 | 56 | 0.93 |
| Center 1 = MUV [%] | 69 | 61 | 63 | 0.89 |
| Center 2 = KFJ [%] | 6 | 22 | 19 | 0.44 |
| Center 3 = SMZ [%] | 25 | 17 | 19 | 0.83 |
| Age [years] | 63 ± 13 | 62 ± 16 | 61 ± 17 | 0.94 |
| Time on Dialysis [years] | 3.1 ± 2.5 | 1.9 ± 1.7 | 3.2 ± 1.8 | 0.10 |
| Height [cm] | 174 ± 11 | 169 ± 7 | 170 ± 12 | 0.38 |
| Body Mass Index [kg/m2] | 24.7 ± 6.1 | 24.3 ± 4.6 | 22.6 ± 4.4 | 0.48 |
| No Antihypertensives [%] | 0 | 17 | 0 | 0.06 |
| -Alpha Blockers [%] | 50 | 33 | 31 | 0.61 |
| -Beta Blockers [%] | 81 | 56 | 69 | 0.39 |
| -ACEI/ARB [%] | 56 | 56 | 31 | 0.58 |
| -Calcium Channel Blockers [%] | 56 | 50 | 63 | 0.29 |
| -Vasodilators [%] | 25 | 17 | 44 | 0.66 |
| -‘Central’ Antihypertensives [%] | 25 | 28 | 31 | 0.42 |
| -Diuretics [%] | 25 | 28 | 25 | 0.71 |
| Central Venous Catheters [%] | 50 | 56 | 25 | 0.17 |
| Hemodiafiltration [%]++ | 31 | 28 | 31 | 0.97 |
| Ethnicity | ||||
| Caucasian [%] | 100 | 89 | 94 | 0.41 |
| African/Black [%] | 0 | 0 | 6 | 0.35 |
| Asian [%] | 0 | 11 | 0 | 0.16 |
| Type 1 DM [%] | 0 | 6 | 0 | 0.46 |
| Type 2 DM [%] | 31 | 28 | 25 | 0.93 |
| Kidney Disease | ||||
| Vascular [%] | 19 | 0 | 19 | 0.15 |
| Glomerular [%] | 13 | 22 | 19 | 0.77 |
| Polycystic [%] | 6 | 0 | 13 | 0.32 |
| Tubulointerstitial [%] | 13 | 22 | 13 | 0.68 |
| Diabetic Glomerulosclerosis [%] | 25 | 17 | 19 | 0.83 |
| Unknown [%] | 25 | 39 | 19 | 0.42 |
CONV conventional hemodialysis, UTR ultrafiltration and temperature regulation, UCR ultrafiltration and dialysate conductivity regulation, N number, DM diabetes mellitus
ITT analysis. +Overall p-values determined by analysis of variance. ++All other patients on hemodialysis